Search: 

What's new


Be one in a million!

Make Parkinson’s a health, research, social, and economic priority around the world and help Canada do its part to build a global Parkinson’s movement. Make your vote count. Read more and sign the Global Parkinson’s Pledge today!

Read more.



The 2013 World Parkinson Congresses announces co-chairs.

Dr. Jon Stoessl & Dr.Stanley Fahn have been tapped to co-chair the third World Parkinson Congress in Montreal Quebec. When asked about his appointment as co-chair, Dr. Jon Stoessl said "I am delighted to co-chair the third World Parkinson Congress and look forward to an outstanding program and experience for the delegates who join us in Montreal, Canada, October 2013. Dr. Stanley Fahn, founder and President of the World Parkinson Coalition, and co-chair of the first two World Parkinson Congresses, will stay on board as co-chair of the WPC 2013. “I am honored and pleased to co-chair the third World Parkinson Congress with Dr. Stoessl.”

Read the announcement here.




Scientists find 5 new Parkinson’s genes

Scientists have identified five new genes linked to Parkinson's disease in a large genetic analysis of the illness, according to a new study.

Learn more about the discovery here.




Leukemia drug holds promise for Parkinson's

A drug already used in some leukemia patients prevented brain cells linked to Parkinson's disease from being destroyed in mice, a finding that could point to a way to slow progression of the disease, San Antonio researchers are reporting today.

http://www.mysanantonio.com/life/health/article/Leukemia-drug-holds-promise-for-Parkinson-s-937294.php




The House of Commons voted today to support motion M-574

The House of Commons voted today to support the motion tabled by Mr. James Rajotte (Conservative). Four MPs spoke to the motion - Paul Dewar (NDP) Ottawa Centre; Scott Brison (Lib) Kings - Hants; Kelly Block (Con) Saskatoon-Rosetown-Biggar; James Rajotte (Con) Edmonton-Leduc.

Here is the motion:

M-574 — October 28, 2010 — On or after Friday, November 19, 2010 — Resuming consideration of the motion of Mr. Rajotte (Edmonton—Leduc), seconded by Mr. Calandra (Oak Ridges—Markham), — That, in the opinion of the House, the government should continue to address the rising financial and human costs of Alzheimer's disease and other forms of dementia in Canada by ensuring, now and in the future, that its programs and policy development related to this issue continue to recognize: (a) the right to dignity and compassion of patients stricken by such conditions; (b) the emotional and psychological toll on family members and friends of patients afflicted by such conditions; (c) the increasing costs imposed on public health systems by the treatment of such conditions; and (d) the role played by such civil organizations as the Alzheimer Society of Canada and Neurological Health Charities Canada in furthering our understanding of the impacts of Alzheimer's disease and other forms of dementia;

And of the amendment of Mr. Malo (Verchères—Les Patriotes), seconded by Mr. Lessard (Chambly—Borduas), — That the motion be amended by adding after the words “the government” the following:

“, with regard to matters under the Parliament of Canada's legislative jurisdiction,”.

Debate — 1 hour remaining, pursuant to Standing Order 93(1).

Voting — at the expiry of the time provided for debate, pursuant to Standing Order 93(1).

All members referenced the Rising Tide report, produced by the Alzheimer Society of Canada last January (authored by Scott Dudgeon). The two Conservative members also spoke about the work of the NHCC (Neurological Health Charities Canada) and the collective vision for a broader brain strategy for Canada. Ms. Kelly Block spoke at length about the work that the government already has underway including:

  • National Population Health Study of Neurological Conditions (in collaboration with the NHCC)
  • a new 3-year research program exploring issues related to informal caregiving
  • a national survey on informal caregiving planned for 2012.



The Parliamentary Subcommittee on Neurological Diseases
The Parliamentary Subcommittee on Neurological Diseases has been hearing testimony from various witnesses over the past several weeks. Listen to the audio recording of the Parkinson's testimony from November 23, 2010.



UPDATE: Genetic discrimination
On June 10, 2010, the US Food and Drug Administration sent regulatory letters to five direct-to-consumer genetic testing companies requesting that they obtain FDA approval or clearance for their tests. The companies are: 23andMe, deCODE Genetics, Illumina Inc., Navigenics and Knome.



Legacy Climb 2010 Steve Bull Legacy Climb 2010

Support Steve Bull in his climb to the top of Mt. Kilimanjaro & Mt. Kenya - in honour of his Grandfather, Lorne Bull, who had Parkinson's disease.

Visit legacyclimb2010.com for more information.



Quebec Symposium on Neurodegenerative Disease Therapeutics Quebec Symposium on Neurodegenerative Disease Therapeutics
June 3rd and 4th, 2010
This symposium will bring together clinicians and researchers working on the understanding and development of therapeutic strategies for neurodegenerative diseases, specifically deep brain stimulation and cell transplantation. 

Event info »



MP Patrick Brown speaks in the House of Common about Parkinson's